Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
Sex-Based Differences in Lipid Management: Implications for Cardiovascular Risk
Behind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell Therapies
Irene Caruso
VICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEF
Carolyn Lam, MD
Managing Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
Improving Lipid Management Through Equity-Focused Clinical Strategies
Triglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
From Risk to Results: Cases in ASCVD Prevention and Treatment
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Riccardo Maria Inciardi, MD, PhD
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
Bridging ASCVD Care Between Academic and Rural Settings
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
Target in Sight: Escalating Therapy to Reach LDL-C Goals
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.